跳至主要内容
临床试验/ISRCTN16690312
ISRCTN16690312进行中(未招募)Unknown

Transversal study of early-onset gastrointestinal cancer

avarre Institute of Health Research0 个研究点目标入组 240 人开始时间: 2024年5月2日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Newly diagnosed, histologically confirmed colorectal adenocarcinoma (CRC, group A), gastroesophageal adenocarcinoma (GEC, group B) and pancreatic adenocarcinoma (PC, group C)
  • 2. Aged 18-50 years (both included) years old for the EOGIC group, and aged 60-75 years (both included) years old for the non-EOGIC group

排除标准

  • 1. Eastern Cooperative Oncology Group (ECOG) performance status of =3
  • 2. Presence of comorbidities which may compromise participation of the patient in the study (mainly in terms of capability to complete the questionnaires)
  • 3. Having received oncological treatment directed at the newly diagnosed cancer (i.e., at the time of inclusion the patient has not yet started any type of treatment, including surgery)

研究者

发起方
avarre Institute of Health Research

相似试验